Pfizer, Dexcel Drop Heart Drug Case Before Bench Trial
Pfizer and Israeli generic-drug maker Dexcel on Friday agreed to drop a case Pfizer brought to block Dexcel from creating a generic version of the heart medication Vyndamax....To view the full article, register now.
Already a subscriber? Click here to view full article